Workflow
信息披露违规
icon
Search documents
动力新科:收到上海证监局行政监管措施决定书
Xin Lang Cai Jing· 2025-08-05 08:40
动力新科公告,公司收到上海证监局行政监管措施决定书,指出公司存在收入错报和未按规定审议并披 露与重卡汇的关联关系及关联交易的问题。具体包括2019年至2023年,子公司上汽红岩在部分商品控制 权尚未实现转移的情况下确认了销售收入,导致收入相关数据不准确。同时,公司未及时披露与重卡汇 的关联关系和关联交易,且2021年与重卡汇的关联交易未经股东大会审议。根据《信披办法》第五十二 条第一项规定,上海证监局决定对公司采取责令改正的监督管理措施,并要求在三十日内予以改正并提 交书面报告。 ...
连亏股清越科技信披违规等收警示函 2022上市超募3亿
Zhong Guo Jing Ji Wang· 2025-08-05 06:49
Core Viewpoint - Qingyue Technology received a warning letter from the Jiangsu Securities Regulatory Bureau due to multiple regulatory violations related to fundraising and financial reporting practices [1][2][3] Group 1: Regulatory Violations - The company misused raised funds by transferring them to a general settlement account to purchase bank wealth management products in 2023 [2] - The financial accounting for the CTP+OLED product trading business was not compliant, as the company reported revenue using the gross method instead of the net method, leading to a correction of 13.67 million yuan in the third quarter report of 2023 [2][3] - An undisclosed related party transaction occurred with Zaozhuang Hongyuan Construction Engineering Company, controlled by a close relative of the company's actual controller, involving a payment of 3.63 million yuan for engineering contracts [2][3] Group 2: Consequences and Company Background - The violations led to a warning letter being issued to Qingyue Technology, its chairman Gao Yudi, and secretary Zhang Xiaobo, which will be recorded in the securities market integrity archive [3] - Qingyue Technology went public on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 28, 2022, raising a total of 824.4 million yuan, with a net amount of 734.95 million yuan after expenses [3][4] - The company has reported losses for two consecutive years, with net profits of -118 million yuan, -69.49 million yuan, and -15.99 million yuan for the first quarters of 2023, 2024, and 2025, respectively [4]
ST信通及董事长袁义祥等因未及时披露对外投资进展被警示
Sou Hu Cai Jing· 2025-08-05 01:22
雷达财经 文|杨洋 编|李亦辉 8月4日,亿阳信通股份有限公司(证券代码:600289,证券简称:ST信通)公告,公司于2025年8月4日收到中国证券监督管理委员会黑龙江监管局的行政 监管措施决定书。决定书指出,公司在2023年8月5日披露拟向北京多来点信息技术有限公司投资不超过2.5亿元的公告后,未及时披露相关交易进展情况, 直至2024年4月30日才在另一份公告中披露已支付2000万元诚意金但最终未达成交易的情况。 公司及公司董事长袁义祥、时任总裁曹星、财务总监张秀琴、董事会秘书陶恒亮因未履行勤勉尽责义务,被黑龙江证监局采取出具警示函的行政监管措施, 并记入证券期货市场诚信档案。 公司表示将积极整改,加强法律法规学习,提高内控管理水平,确保信息披露的真实、准确、完整、及时。此次行政监管措施不会对公司日常生产经营产生 重大影响。 天眼查资料显示,ST信通成立于1995年01月18日,注册资本63105.2069万人民币,法定代表人袁义祥,注册地址为哈尔滨市南岗区嵩山路高科技开发区1号 楼。主营业务为信息通信技术(ICT)运营管理领域的基础软件和应用软件的研发,面向电信运营商及各大行业客户提供运营支撑系统(O ...
未及时披露对外投资交易相关进展 ST信通收行政监管措施决定书
8月4日晚间ST信通(600289)公告收到中国证券监督管理委员会黑龙江监管局(下称"黑龙江证监局")下 达的《行政监管措施决定书》,黑龙江证监局对公司相关责任人员采取出具警示函措施的决定。 根据《上市公司信息披露管理办法》(证监会令第182号)第五十一条、第五十二条的规定,黑龙江证监 局决定对ST信通、袁义祥、曹星、张秀琴、陶恒亮分别采取出具警示函的行政监管措施,并记入证券 期货市场诚信档案。公司及有关责任人应严格按照法律法规规定履行信息披露义务,并在收到本决定书 之日起30日内向该局提交书面报告。 行政监管措施决定书显示,如果对本监督管理措施不服,可以在收到本决定书之日起60日内向中国证券 监督管理委员会提出行政复议申请,也可以在收到本决定书之日起6个月内向有管辖权的人民法院提起 诉讼。复议与诉讼期间,上述监督管理措施不停止执行。 在此番公告披露之前,ST信通股价在8月4日录得涨停,当日报涨4.98%,收于6.74元/股。 不过此后,该公司未再披露相关事项进展,迟至2024年4月30日公司才在《关于债权转让暨关联交易的 公告》中披露,公司已于2023年9月28日根据多来点付款指令向其支付2000万元诚意金 ...
倍轻松再爆实控人马学军占用上市公司资金
Xin Lang Cai Jing· 2025-08-04 09:42
Core Viewpoint - The actual controller of Beiliang Company, Ma Xuejun, has been found to have occupied company funds through various means, raising concerns about financial transparency and governance [1][4][5]. Group 1: Fund Occupation Details - From October 2021 to the end of 2022, Ma Xuejun occupied a total of 408,230 yuan through employee loans [1]. - Additionally, the company made advance payments totaling 8 million yuan to a supplier, which were later identified as funds occupied by Ma Xuejun [3]. - The occupied funds have been returned, but the interest accrued remains a concern for regulatory compliance [4]. Group 2: Regulatory Implications - The occupation of funds by the major shareholder may lead to regulatory penalties, as it constitutes a violation of information disclosure obligations [4][5]. - Legal experts indicate that the actions could potentially violate securities laws and may result in criminal charges if certain conditions are met [5][6]. Group 3: Company Financial Performance - Beiliang Company has reported continuous losses over the past three years, with revenues of 895 million yuan, 1.275 billion yuan, and 1.085 billion yuan from 2022 to 2024, respectively [7]. - The net profit figures for the same period were -124 million yuan, -50.24 million yuan, and 1.019 million yuan, indicating a lack of significant recovery [7]. - High sales expenses have been a persistent issue, with sales expenses reaching 482 million yuan, 680 million yuan, and 544 million yuan, leading to high sales expense ratios [9]. Group 4: Market Position and Strategy - The company primarily relies on direct sales and has established a significant presence in physical retail locations, which incurs high fixed costs [11]. - The product category is characterized as non-essential, leading to reliance on promotional activities to drive sales, which further increases marketing costs [11]. - There is potential for improvement in sales efficiency and cost management, but the company is currently in an expansion phase that necessitates high marketing expenditures [11].
黑芝麻拟换老板,有人发帖“神预言”,公司回应
Core Viewpoint - Black Sesame (000716.SZ) announced that its controlling shareholder, Guangxi Black Five Categories Food Group, is planning to transfer its shares, which may lead to a change in company control. The stock will be suspended for up to two trading days starting August 4, 2025 [1]. Group 1: Share Transfer and Control Change - The controlling shareholder intends to transfer approximately 20% of the company's total shares to a state-owned enterprise in Guangxi's cultural tourism and health industry [1]. - The involved parties are currently discussing the specific transaction plan and agreements, but no formal agreements have been signed yet [1]. Group 2: Stock Performance - Black Sesame's stock price has been volatile this year, with a decline of 4.94% from the beginning of the year. As of August 1, the stock closed at 6.54 CNY per share, with an intraday increase of 4.81% [2]. Group 3: Information Disclosure Issues - The company has faced multiple issues regarding information disclosure, including a warning letter from the Guangxi Securities Regulatory Bureau for non-operational fund occupation and unauthorized external guarantees [4]. - Significant disclosure failures were noted, such as the failure to timely disclose the occupation of company funds by the controlling shareholder and related parties [4]. Group 4: Financial Performance - Black Sesame's financial performance has been poor in recent years, with revenue only slightly increasing in 2021, while other years saw significant declines. The net profit fluctuated dramatically, with losses exceeding 200 million CNY in 2021 and 2022, followed by a slight recovery in 2023 and 2024 [6]. - In Q1 2025, the company reported revenue of 442 million CNY, a year-on-year decrease of 3.74%, and a net profit of 2.25 million CNY, down 29.61% year-on-year [6]. Group 5: Past Business Ventures - Black Sesame has attempted several cross-industry transformations that did not meet expectations, including a 256 million CNY acquisition of a logistics park in 2015, which was divested two years later [6]. - The company also invested 700 million CNY in an e-commerce platform, which faced performance issues, leading to a reduction in its e-commerce operations in 2024 [6]. - In 2023, Black Sesame announced a 3.5 billion CNY investment in the energy storage battery sector, but the project was suspended a year later due to market conditions [6].
潞安环能信披违规董秘收警示函 广发证券精准预测高点
Zhong Guo Jing Ji Wang· 2025-08-04 08:29
中国经济网北京8月4日讯潞安环能(601699)(601699.SH)2日发布关于收到山西证监局警示函的公告。 潞安环能于近日收到中国证券监督管理委员会山西监管局(以下简称"山西证监局")出具的《关于对山西 潞安环保能源开发股份有限公司、马泽锋采取出具警示函措施的决定》(行政监管措施决定书〔2025〕 30号,以下简称"警示函")。 潞安环能与山西潞安工程有限公司、山西潞安煤炭经销有限责任公司等关联方2024年度实际发生的日常 关联交易超出年度预计金额。公司未对超出预计金额的关联交易及时履行股东大会审议程序和信息披露 义务。 广发证券股份有限公司研究员沈涛、安鹏、宋炜2024年2月20日发布研报《潞安环能:1月商品煤销量同 比+6.7%喷吹煤龙头估值股息具备优势》称,给予公司24年8倍PE,对应合理价值27.27元/股,维持"买 入"评级。 2024年3月7日,潞安环能盘中创下历史高点28.58元。 上述行为违反了《上市公司信息披露管理办法》(证监会令第182号,下同)第三条第一款、第四十一条 的规定。公司董事会秘书马泽锋对上述违规行为负有主要责任。按照《上市公司信息披露管理办法》第 五十二条的规定,山西证监 ...
长盈精密因关联交易未及时披露收监管函,66岁董事长陈奇星年薪84万元
Sou Hu Cai Jing· 2025-08-04 07:48
Group 1 - The core issue involves Changying Precision's failure to timely disclose related party transactions amounting to 42.46 million yuan, which represents 0.73% of the company's audited net assets as of the end of 2023 [2] - The Shenzhen Stock Exchange has pointed out that Changying Precision's actions violate regulations and has urged the board to take the matter seriously, rectify the issue promptly, and prevent recurrence [2] - The board members are reminded to ensure that information disclosure is truthful, accurate, complete, and free from false records, misleading statements, or significant omissions, and they bear individual and joint responsibility [2] Group 2 - In the 2024 annual report, Changying Precision reported a revenue of 16.934 billion yuan, reflecting a year-on-year growth of 23.40% [4] - The net profit attributable to shareholders reached 772 million yuan, showing a remarkable increase of 800.24% year-on-year, while the non-recurring net profit attributable to shareholders surged by 2750.70% to 531 million yuan [4] - The basic earnings per share for the company stood at 0.60 yuan [4]
嘉应制药因信披违规收到证监会490万元罚单
Jing Ji Guan Cha Wang· 2025-08-04 07:05
Core Viewpoint - On August 1, 2023, Jiaying Pharmaceutical (002198) received an administrative penalty notice from the Guangdong Regulatory Bureau of the China Securities Regulatory Commission (CSRC) for failing to timely disclose 220 million yuan in related party fund borrowing, resulting in fines for the company and its responsible persons [1][2]. Group 1: Administrative Penalties - Jiaying Pharmaceutical was fined 1.5 million yuan, while its chairman Li Neng was fined 160,000 yuan, general manager You Yongping 100,000 yuan, and former financial director Shi Junping 80,000 yuan, totaling 4.9 million yuan [1][2]. - The violations involved non-operating fund transactions that were not disclosed until the 2024 annual report, constituting a breach of the Securities Law [2]. Group 2: Company Background - Jiaying Pharmaceutical is a traditional Chinese medicine manufacturer established in 2003, with R&D, production, and sales bases in Changsha, Hunan Province, and Meizhou, Guangdong Province [3][4]. - As of August 4, 2025, the company's total market value was 3.517 billion yuan, with a product portfolio that includes 70 approved drug varieties across various therapeutic areas [4].
三项行为违规,清越科技收警示函!
Ju Chao Zi Xun· 2025-08-02 03:47
Group 1 - The company received a warning letter from the Jiangsu Securities Regulatory Bureau due to several violations, including improper use of raised funds, non-compliance in financial accounting for CTP+OLED product trade, and undisclosed related party transactions [1] - In 2023, the company improperly transferred raised funds to a general settlement account to purchase bank wealth management products [1] - The company recognized revenue for CTP+OLED product trade using the gross method instead of the net method, leading to a correction in the third quarter report, reducing revenue and cost by 13.67 million yuan [1] Group 2 - The company specializes in the research, production, and sales of OLED and other new display devices [2] - In the 2024 annual report, the company achieved operating revenue of 753 million yuan, a year-on-year increase of 13.96%, while the net profit attributable to shareholders was a loss of 69.49 million yuan, which is a reduction in loss by 48.44 million yuan compared to the previous year [2] - In the first quarter of the current year, the company reported total revenue of 172 million yuan, a year-on-year growth of 4.83%, with a net profit loss of 15.99 million yuan, which is an increase in loss compared to 8.00 million yuan in the same period last year [2]